ArticleAmerican journal of nuclear medicine and molecular imaging2014

Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer.

Katherine A Vallis et al.PubMed ↗Full text ↗

No numbers read from the abstract.